Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Research in Genodermatoses and Epidermolysis Bullosa, |
RCV002277067 | SCV002499358 | pathogenic | Recessive dystrophic epidermolysis bullosa | 2022-03-14 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV002246697 | SCV002516281 | likely pathogenic | Transient bullous dermolysis of the newborn | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003560874 | SCV004292716 | pathogenic | not provided | 2024-10-09 | criteria provided, single submitter | clinical testing | This sequence change affects codon 2339 of the COL7A1 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the COL7A1 protein. This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has been observed in individual(s) with autosomal recessive epidermolysis bullosa dystrophica (PMID: 19681861, 35979658). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 1676631). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |